{"transactions":[{"id":751412,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:26:24.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001872863-26-000004","document":"form4-06032026_090620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000187286326000004/form4-06032026_090620.xml","form_type":"4"}},{"id":946163,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:22:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3355,"price":8.42,"value":28249.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.\""}],"balance_after":47963,"source":{"system":"sec-edgar","filing":"0001872863-26-000002","document":"form4-01062026_100121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000187286326000002/form4-01062026_100121.xml","form_type":"4"}},{"id":1124622,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:18:43.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019295","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019295/rdgdoc.xml","form_type":"4"}},{"id":1314216,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:15:16.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5290,"price":5.34,"value":28248.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $28,250.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan."}],"balance_after":44608,"source":{"system":"sec-edgar","filing":"0001235802-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000001/primary_doc.xml","form_type":"4"}},{"id":1494974,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:35:21.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000049","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000049/primary_doc.xml","form_type":"4"}},{"id":1696368,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T22:05:18.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":9375,"price":2.8,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,375 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":39318,"source":{"system":"sec-edgar","filing":"0001235802-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000005/primary_doc.xml","form_type":"4"}},{"id":1844118,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:26:41.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":12787,"price":3.91,"value":49997.17,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":29943,"source":{"system":"sec-edgar","filing":"0001235802-23-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000071/primary_doc.xml","form_type":"4"}},{"id":1869422,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:33:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":16968,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001235802-23-000060","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000060/primary_doc.xml","form_type":"4"}},{"id":2072461,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:25:36.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":17156,"price":1.53,"value":26248.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":17156,"source":{"system":"sec-edgar","filing":"0001235802-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000002/primary_doc.xml","form_type":"4"}},{"id":2247261,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T20:34:09.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":13222,"derivative":{"exercise_price":2.45,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":13222},"source":{"system":"sec-edgar","filing":"0001235802-22-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000070/primary_doc.xml","form_type":"4"}},{"id":2631887,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41697,"kind":"person","name":"Semba Charles Pauling","position":1,"cik":"0001872863","reported_name":"Semba Charles Pauling","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-16T20:21:43.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":18786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in twelve nearly equal quarterly installments over three years."}],"balance_after":18786,"derivative":{"exercise_price":3.64,"expiration_date":"2031-07-14","underlying":"Common  Shares","underlying_shares":18786},"source":{"system":"sec-edgar","filing":"0001235802-21-000077","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000077/primary_doc.xml","form_type":"4"}}]}